those

Nutriband’s Innovative Patent Breaks New Ground in Transdermal Medications

Revolutionary AVERSA™ Technology Sets New Standard for Opioid Patch Safety ORLANDO, FL / September 20, 2023 - Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal pharmaceutical products, proudly announces the issuance of a U.S. patent for its cutting-edge AVERSA™ Technology. This groundbreaking innovation, utilizing taste aversion, marks a paradigm shift in addressing the primary routes of abuse associated with opioid-based transdermal patches. The newly granted patent, numbered U.S. patent 11,759,431, titled "Abuse and Misuse Deterrent Transdermal Systems," significantly bolsters Nutriband's intellectual property protection in the United States. It covers

Blockpass integrates award-winning ID system with Solana Wallets, offers special discount to Solana projects

HONG KONG, Sept 7, 2023 - (ACN Newswire) - Blockpass has announced that it will be integrating its identity verification solution with Solana Wallets and supporting Solana projects with its revolutionary On-Chain KYC(R) solution. Additionally, Blockpass will provide a unique special offer available to all Solana projects in the form of a 50% discount. Solana is a blockchain network with the fundamental ideals of an open-source community, decentralization, staking and censorship resistance at its heart. The Solana network is validated by thousands of independently-operating nodes that ensures data remains secure

American Picture House Corporate Update

New York, NY, Raleigh, NC, and Los Angeles, CA.  September 6, 2023 – American Picture House Corporation (OTC: APHP), an entertainment company with a focus on producing feature films, limited series, and entertainment enhancing technologies, today provided a corporate update for shareholders. Industry Strikes American Picture House supports the ideals behind the two current industry strikes -- brought by the Writers Guild of America (“WGA”) and the Screen Actors Guild (“SAG”) -- and joins the many reasonable voices urging for a fair and timely resolution. Update on Feature Films -

The Collision of Titans: AI and Web3

Over the past decade, two titans have emerged from the tech realm, each promising to redefine the very fabric of our global infrastructure - Artificial Intelligence (AI) and Web3. But what happens when these two forces converge? Are we on the brink of a new digital renaissance or a potentially uncharted dystopia? Consider this: AI is, at its core, the embodiment of advanced logic and decision-making, a machine's ability to "think" and process information in ways eerily similar to humans. It's no longer just about algorithms; it's about creating synthetic

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

Livento Group, Inc. Announces Second Quarter Results with Revenue Growth of Over 90%, Including Significant Achievements and Updates

NEW YORK, NY / August 14, 2023 / NuGene International, Inc./Livento Group, Inc. (OTC Pink:NUGN), a dynamic leader specializing in the acquisition and development of companies with disruptive business models in film, content, and technology sectors, is pleased to announce revenue growth of 91.65% for the second quarter of 2023, compared to the same period in 2022. Financial Highlights: Revenue Growth:The second quarter ending June 30, 2023, saw revenues of $431,184, up from $224,986 in 2022. For the six-month period ending June 30, 2023, revenues grew from $680,202 to $922,651, a growth of

Prontoblock and Mercantile Bank International Partner to Modernize the $1.25 Trillion Commercial Paper Market Through Tokenization

New York, August 10, 2023 – Prontoblock, a leading digital asset fintech company, is pleased to announce its strategic partnership with Mercantile Bank International (MBI). This partnership aims to revolutionize the commercial paper market through the tokenization of these financial instruments. This partnership will empower MBI clientele to engage in the purchase and issuance of tokenized commercial paper using Prontoblock’s cutting-edge digital assets platform. Prontoblock will collaborate closely with issuers to identify the most suitable commercial paper instruments for tokenization. The outstanding value of U.S. commercial paper exceeded $1.25 trillion

Stablecoins Under Scrutiny

Amidst the market’s recovery from the recent onslaught of SEC crackdowns, rumors swirl over the potential targeting of stablecoins in their crosshairs. Such a move could have profound implications for cryptocurrency prices, making it crucial to gauge the likelihood of this scenario and the approach regulators might adopt. The largest stablecoins by market cap are Tether’s USDT and Circle’s USDC. Both are pegged to the US dollar and backed by various assets, typically highly liquid instruments like US Treasury bills. In theory, when someone wants to buy stablecoins from an

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating

Dynamic Rewards Unleashed

Following weeks of preparation and hard work, we’re incredibly excited to open the Paribus Mainnet v1 tomorrow. This marks the welcome return of our protocol and heralds the beginning of our rewards program. For those who participated in our staking program, the concept behind the rewards program will be simple to understand. We’ve allocated 100 million PBX tokens to be issued as rewards to borrowers on the platform. This concept is even more exciting because the rewards are scheduled to be released evenly across every block and are anticipated to

Tokenovate and GMEX ZERO13 Enable Execution of World’s First Smart Legal Contract for Voluntary Carbon Credit Derivatives Trades using ISDA Definitions.

BSV Blockchain based smart legal contract powers successful trade execution and settlement. London, May 31, 2023 - Tokenovate, a financial services company providing distributed financial market infrastructure (dFMI) enabling programmatic lifecycle event management of the pre-trade to post-trade workflow for OTC and Exchange traded derivatives, and ZERO13, a GMEX Group initiative, providing a digital climate fintech aggregation ecosystem announce the successful execution of the world's first smart legal contract for voluntary carbon credit (VCC) derivatives trades referencing the 2022 ISDA (The International Swaps and Derivatives Association) Verified Carbon Credit Transactions